How were Stellar Biotechnologies' earnings last quarter?

Stellar Biotechnologies Inc (NASDAQ:SBOT) released its earnings results on Wednesday, May, 8th. The biotechnology company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analysts' expectations of $0.11 million. Stellar Biotechnologies had a negative trailing twelve-month return on equity of 51.12% and a negative net margin of 1,782.64%.

When did Stellar Biotechnologies' stock split?

Shares of Stellar Biotechnologies reverse split on Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 4th 2018. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

What other stocks do shareholders of Stellar Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include Heat Biologics (HTBX) , XOMA (XOMA) , Anavex Life Sciences (AVXL) , EyePoint Pharmaceuticals (EYPT) , OPKO Health (OPK) , Rigel Pharmaceuticals (RIGL) , Statoil ASA (STO) , Abraxas Petroleum (AXAS) and Carrizo Oil & Gas (CRZO) .

NASDAQ:SBOT

Stellar Biotechnologies (SBOT) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free SBOT Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $2.75
▼
$4.96
50-Day Range: $4.44
▼
$298,098.00
52-Week Range: $0.75
▼
$3.25

Volume: 3.74 million shs
Average Volume: 2.95 million shs
Market Capitalization: $16.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Stellar Biotechnologies alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Stellar Biotechnologies Stock (NASDAQ:SBOT)

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. It provides its KLH protein under the Stellar KLH brand. The company's products include Stellar KLH protein in various grades, formulations, custom configurations, and fill finishes for drug development and research applications, as well as KLH-based in vitro diagnostic kits for research and preclinical use. Its customers and partners comprise biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

SBOT Stock News Headlines

April 18, 2024 | techcrunch.com

Uber, Nvidia-backed Serve Robotics hits public markets with $40M splash

July 30, 2023 | nypost.com

Zach Wilson’s stellar day at Jets camp includes long touchdown throw

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

June 7, 2023 | forbes.com

Caterpillar's Stellar Move To Attract High-Quality Employees

February 26, 2023 | benzinga.com

Stellar Bancorp, Inc. Declares Quarterly Dividend

October 5, 2022 | cbsnews.com

O's closer Felix Bautista goes on DL ending stellar rookie year

See More Headlines

Receive SBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stellar Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/08/2019
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:SBOT
CUSIP: N/A
CIK: 1540159
Web: www.stellarbiotechnologies.com
Phone: 805-488-2800
Fax: N/A
Employees: 25
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.76)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,030,000.00
Net Margins: -1,782.64%
Pretax Margin: N/A
Return on Equity: -51.12%
Return on Assets: -48.37%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.24
Quick Ratio: 8.96

Sales & Book Value

Annual Sales: $210,000.00
Price / Sales: 134.52
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.12 per share
Price / Book: 2.50

Miscellaneous

Outstanding Shares: 5,330,000
Free Float: N/A
Market Cap: $28.25 million
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Frank R. Oakes (Age 69)
Chairman, Pres & CEO
Ms. Kathi Niffenegger CPA (Age 62)
CFO & Corp. Sec.
Mr. Gary Koppenjan
Sr. Director of Investor Relations & Communications
Brando Lincicum
Exec. Director of Aquaculture and Facility Operations

Key Competitors

View All Competitors

SBOT Stock Analysis - Frequently Asked Questions

How were Stellar Biotechnologies' earnings last quarter?: Stellar Biotechnologies Inc (NASDAQ:SBOT) released its earnings results on Wednesday, May, 8th. The biotechnology company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analysts' expectations of $0.11 million. Stellar Biotechnologies had a negative trailing twelve-month return on equity of 51.12% and a negative net margin of 1,782.64%.
When did Stellar Biotechnologies' stock split?: Shares of Stellar Biotechnologies reverse split on Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 4th 2018. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.
What other stocks do shareholders of Stellar Biotechnologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include Heat Biologics (HTBX), XOMA (XOMA), Anavex Life Sciences (AVXL), EyePoint Pharmaceuticals (EYPT), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL), Statoil ASA (STO), Abraxas Petroleum (AXAS) and Carrizo Oil & Gas (CRZO).

This page (NASDAQ:SBOT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Stellar Biotechnologies (SBOT) Stock Price, News & Analysis

About Stellar Biotechnologies Stock (NASDAQ:SBOT)

SBOT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SBOT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info